Scandinavian Medical Solutions Valuation

Is SMSMED undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SMSMED when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SMSMED's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SMSMED's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SMSMED?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for SMSMED. This is calculated by dividing SMSMED's market cap by their current preferred multiple.
What is SMSMED's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	DKK 167.21m

SMSMED key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1x
Enterprise Value/EBITDA	13.8x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does SMSMED's PE Ratio compare to its peers?

The above table shows the PE ratio for SMSMED vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	27.3x
QMSMEDI QMS Medical Allied Services	22.9x	n/a	₹2.1b
WINMED Winnergy Medical	31.5x	n/a	฿800.0m
SEI SEI Medical	35.8x	34.7%	฿960.5m
INDIES Indies Pharma Jamaica	18.9x	n/a	JA$4.1b
SMSMED Scandinavian Medical Solutions	31.1x	n/a	DKK 167.2m

Price-To-Earnings vs Peers: SMSMED is expensive based on its Price-To-Earnings Ratio (31.1x) compared to the peer average (27.3x).

Price to Earnings Ratio vs Industry

How does SMSMED's PE Ratio compare vs other companies in the European Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	20.6%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	20.6%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: SMSMED is expensive based on its Price-To-Earnings Ratio (31.1x) compared to the European Healthcare industry average (18.5x).

Price to Earnings Ratio vs Fair Ratio

What is SMSMED's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SMSMED PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	31.1x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SMSMED's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.